Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1984 September; 74(3): 936–941.
PMCID: PMC425250

Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate.


Consumption of alcohol causes hyperuricemia by decreasing urate excretion and increasing its production. Our previous studies indicate that ethanol administration increases uric acid production by increasing ATP degradation to uric acid precursors. To test the hypothesis that ethanol-induced increased urate production results from acetate metabolism and enhanced adenosine triphosphate turnover, we gave intravenous sodium acetate, sodium chloride and ethanol (0.1 mmol/kg per min for 1 h) to five normal subjects. Acetate plasma levels increased from 0.04 +/- 0.01 mM (mean +/- SE) to peak values of 0.35 +/- 0.07 mM and to 0.08 +/- 0.01 mM during acetate and ethanol infusions, respectively. Urinary oxypurines increased to 223 +/- 13% and 316 +/- 44% of the base-line values during acetate and ethanol infusions, respectively. Urinary radioactivity from the adenine nucleotide pool labeled with [8-14C] adenine increased to 171 +/- 27% and to 128 +/- 8% of the base-line values after acetate and ethanol infusions. These data indicate that both ethanol and acetate increase purine nucleotide degradation by enhancing the turnover of the adenine nucleotide pool. They support the hypothesis that acetate metabolism contributes to the increased production of urate associated with ethanol intake.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • LIEBER CS, DAVIDSON CS. Some metabolic effects of ethyl alcohol. Am J Med. 1962 Sep;33:319–327. [PubMed]
  • LIEBER CS, JONES DP, LOSOWSKY MS, DAVIDSON CS. Interrelation of uric acid and ethanol metabolism in man. J Clin Invest. 1962 Oct;41:1863–1870. [PMC free article] [PubMed]
  • YU TF, SIROTA JH, BERGER L, HALPERN M, GUTMAN AB. Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med. 1957 Dec;96(3):809–813. [PubMed]
  • Maclachlan MJ, Rodnan GP. Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med. 1967 Jan;42(1):38–57. [PubMed]
  • Faller J, Fox IH. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med. 1982 Dec 23;307(26):1598–1602. [PubMed]
  • Edwards NL, Recker D, Airozo D, Fox IH. Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans. J Lab Clin Med. 1981 Nov;98(5):673–683. [PubMed]
  • Edwards NL, Recker D, Fox IH. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage. J Clin Invest. 1979 May;63(5):922–930. [PMC free article] [PubMed]
  • Zakaria M, Brown PR. Investigation of clinical methodology for sample collection and processing prior to the reversed-phase liquid chromatographic determination of UV-absorbing plasma constituents. Anal Biochem. 1982 Feb;120(1):25–37. [PubMed]
  • LIDDLE L, SEEGMILLER JE, LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed]
  • Klinenberg JR, Goldfinger S, Bradley KH, Seegmiller JE. An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine. Clin Chem. 1967 Oct;13(10):834–846. [PubMed]
  • Hartwick RA, Brown PR. Evaluation of microparticle chemically bonded reversed-phase packings in the high-pressure liquid chromatographic analysis of nucleosides and their bases. J Chromatogr. 1976 Nov 3;126:679–691. [PubMed]
  • Gehrke CW, Kuo KC, Davis GE, Suits RD, Waalkes TP, Borek E. Quantitative high-performance liquid chromatography of nucleosides in biological materials. J Chromatogr. 1978 Mar 21;150(2):455–476. [PubMed]
  • Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism. 1981 Jun;30(6):616–634. [PubMed]
  • Diamond HS, Lazarus R, Kaplan D, Halberstam D. Effect of urine flow rate on uric acid excretion in man. Arthritis Rheum. 1972 Jul-Aug;15(4):338–346. [PubMed]
  • LUNDQUIST F, TYGSTRUP N, WINKLER K, MELLEMGAARD K, MUNCK-PETERSEN S. Ethanol metabolism and production of free acetate in the human liver. J Clin Invest. 1962 May;41:955–961. [PMC free article] [PubMed]
  • LUNDQUIST F. Production and utilization of free acetate in man. Nature. 1962 Feb 10;193:579–580. [PubMed]
  • Davis EJ, Davis-van Thienen WI. The effect of acetate oxidation on the endogenous adenine nucleotides of rat heart mitochondria. Biochem Biophys Res Commun. 1977 Dec 21;79(4):1155–1159. [PubMed]
  • Liang CS, Lowenstein JM. Metabolic control of the circulation. Effects of acetate and pyruvate. J Clin Invest. 1978 Nov;62(5):1029–1038. [PMC free article] [PubMed]
  • Skutches CL, Holroyde CP, Myers RN, Paul P, Reichard GA. Plasma acetate turnover and oxidation. J Clin Invest. 1979 Sep;64(3):708–713. [PMC free article] [PubMed]
  • Steffen RP, McKenzie JE, Bockman EL, Haddy FJ. Changes in dog gracilis muscle adenosine during exercise and acetate infusion. Am J Physiol. 1983 Mar;244(3):H387–H395. [PubMed]
  • Halperin ML, Hammeke M, Josse RG, Jungas RL. Metabolic acidosis in the alcoholic: a pathophysiologic approach. Metabolism. 1983 Mar;32(3):308–315. [PubMed]
  • Grunst J, Dietze G, Wicklmayr M, Mehnert H, Hepp KD, Eisenburg J. Einfluss von Athanol auf den Purinkatabolismus der menschlichen Leber. Verh Dtsch Ges Inn Med. 1973;79:914–917. [PubMed]
  • Eliahou HE, Feng PH, Weinberg U, Iaina A, Reisin E. Acetate and bicarbonate in the correction of uraemic acidosis. Br Med J. 1970 Nov 14;4(5732):399–401. [PMC free article] [PubMed]
  • Tolchin N. Acetate metabolism and high efficiency hemodialysis. Int J Artif Organs. 1979 Jan;2(1):1–3. [PubMed]
  • Novello A, Kelsch RC, Easterling RE. Acetate intolerance during hemodialysis. Clin Nephrol. 1976 Jan;5(1):29–32. [PubMed]
  • Mansell MA, Crowther A, Laker MF, Wing AJ. The effect of hyperacetatemia on cardiac output during regular hemodialysis. Clin Nephrol. 1982 Sep;18(3):130–134. [PubMed]
  • Aizawa Y, Ohmori T, Imai K, Nara Y, Matsuoka M, Hirasawa Y. Depressant action of acetate upon the human cardiovascular system. Clin Nephrol. 1977 Nov;8(5):477–480. [PubMed]
  • Kirkendol PL, Devia CJ, Bower JD, Holbert RD. A comparison of the cardiovascular effects of sodium acetate, sodium bicarbonate and other potential sources of fixed base in hemodialysate solutions. Trans Am Soc Artif Intern Organs. 1977;23:399–405. [PubMed]
  • Yamakawa M, Yamamoto T, Kishimoto T, Mizutani Y, Yatsuboshi M, Nishitani H, Hirata S, Horiuchi N, Maekawa M. Serum levels of acetate and TCA cycle intermediates during hemodialysis in relation to symptoms. Nephron. 1982;32(2):155–161. [PubMed]
  • Haddy FJ, Chou CC, Scott JB, Dabney JM. Intestinal vascular responses to naturally occurring vasoactive substances. Gastroenterology. 1967 Feb;52(2):444–451. [PubMed]
  • Dobson JG, Jr, Rubio R, Berne RM. Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res. 1971 Oct;29(4):375–384. [PubMed]
  • Rubio R, Berne RM, Bockman EL, CURNISH RR. Relationship between adenosine concentration and oxygen supply in rat brain. Am J Physiol. 1975 Jun;228(6):1896–1902. [PubMed]
  • Spydevold S, Davis EJ, Bremer J. Replenishment and depletion of citric acid cycle intermediates in skeletal muscle. Indication of pyruvate carboxylation. Eur J Biochem. 1976 Dec;71(1):155–165. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation